BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12537697)

  • 1. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
    Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN
    J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for STAT1 in LPS-induced gene expression in macrophages.
    Ohmori Y; Hamilton TA
    J Leukoc Biol; 2001 Apr; 69(4):598-604. PubMed ID: 11310846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice.
    Salkowski CA; Kopydlowski K; Blanco J; Cody MJ; McNally R; Vogel SN
    J Immunol; 1999 Aug; 163(3):1529-36. PubMed ID: 10415056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells.
    Inoue H; Umesono K; Nishimori T; Hirata Y; Tanabe T
    Biochem Biophys Res Commun; 1999 Jan; 254(2):292-8. PubMed ID: 9918831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
    Marecki S; Atchison ML; Fenton MJ
    J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes.
    Salkowski CA; Barber SA; Detore GR; Vogel SN
    J Immunol; 1996 May; 156(9):3107-10. PubMed ID: 8617930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
    Nguyen H; Mustafa A; Hiscott J; Lin R
    Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
    Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B
    Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages.
    Schroder K; Lichtinger M; Irvine KM; Brion K; Trieu A; Ross IL; Ravasi T; Stacey KJ; Rehli M; Hume DA; Sweet MJ
    J Leukoc Biol; 2007 Jun; 81(6):1577-90. PubMed ID: 17360957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation.
    Nguyen H; Teskey L; Lin R; Hiscott J
    Oncogene; 1999 Sep; 18(39):5455-63. PubMed ID: 10498899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes.
    Grall FT; Prall WC; Wei W; Gu X; Cho JY; Choy BK; Zerbini LF; Inan MS; Goldring SR; Gravallese EM; Goldring MB; Oettgen P; Libermann TA
    FEBS J; 2005 Apr; 272(7):1676-87. PubMed ID: 15794755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo.
    Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF
    J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibitory effects of furonaphthoquinone compound on enzyme activity and lipopolysaccharide-induced expression of cyclooxygenase-2 in macrophages.
    Ahn KY; Kim BH; Lee YR; Hwang DH; Chung EY; Min KR; Kim Y
    Biochem Biophys Res Commun; 2005 Oct; 336(1):93-9. PubMed ID: 16125137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
    Xi H; Goodwin B; Shepherd AT; Blanck G
    Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages.
    Barrios-Rodiles M; Chadee K
    J Immunol; 1998 Sep; 161(5):2441-8. PubMed ID: 9725242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IFN consensus sequence binding protein expression in murine macrophages.
    Kantakamalakul W; Politis AD; Marecki S; Sullivan T; Ozato K; Fenton MJ; Vogel SN
    J Immunol; 1999 Jun; 162(12):7417-25. PubMed ID: 10358195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression.
    Blanco JC; Contursi C; Salkowski CA; DeWitt DL; Ozato K; Vogel SN
    J Exp Med; 2000 Jun; 191(12):2131-44. PubMed ID: 10859338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.